Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee

March 15, 2005

Slides

Tdap Introduction/Background/Presentation of Questions, Dr. Theresa Finn, PhD, FDA (HTM) (PPT)

BOOSTRIX™ GlaxoSmithKline (PPT) (PDF)

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Boostrix™), Dr. Ann Schwartz, MD, FDA (HTM) (PPT)

ADACEL™ Introduction, Martha Monser, FDA (HTM) (PPT)

AP Tdap/ADCEL™, Aventis Pasteur, Ltd (PPT) (PDF)

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Tdap, ADACEL™) Aventis Pasteur, Ltd., Dr. ChrisAnna Mink, MD, FDA (HTM) (PPT)

Open Public Hearing

Written Statement from B. Sachau (HTM) (PDF) (Word)